2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium.

scientific article

2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/TRF.13250
P932PMC publication ID4573332
P698PubMed publication ID26260861

P50authorSteven L. SpitalnikQ46735983
Lisbeth A. WelniakQ104889873
P2093author name stringDana V Devine
Walter H Dzik
Naomi L C Luban
Nareg H Roubinian
Daryl J Kor
Anne F Eder
Cassandra D Josephson
Darrell Triulzi
Simone Glynn
Shimian Zou
Traci Mondoro
Terry Gernsheimer
State of the Science in Transfusion Medicine Working Groups
P2860cites workTransfusion thresholds and other strategies for guiding allogeneic red blood cell transfusionQ24200170
Adverse reactions to allogeneic whole blood donation by 16- and 17-year-oldsQ33156298
Factors associated with fainting: before, during and after whole blood donationQ33159992
A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantationQ33376798
Novel clearance mechanisms of plateletsQ33391541
A survey of transfusion practices in pediatric hematopoietic stem cell transplant patientsQ33404274
Bleeding and coagulopathies in critical careQ33413516
Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME).Q33415825
Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver TransplantationQ33418906
Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell diseaseQ34067039
Increased chest tube drainage is independently associated with adverse outcome after cardiac surgeryQ34234330
Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysisQ34413187
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusionsQ34564925
Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuriesQ34579964
Blood management: transfusion medicine comes of age.Q34652252
Concepts of blood transfusion in adultsQ34652259
Large-scale production of red blood cells from stem cells: what are the technical challenges ahead?Q34658807
Resuscitation and transfusion principles for traumatic hemorrhagic shockQ35174893
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trialQ35219638
Transfusion trigger: when to transfuse?Q35804524
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion managementQ36106307
Effect of processing and storage on red blood cell function in vivoQ36115205
Bleeding in cardiac surgery: its prevention and treatment--an evidence-based reviewQ36181650
Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) studyQ36745315
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery diseaseQ36878553
Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomyQ37060694
Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trialQ37142033
Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS).Q37464134
Risk-based decision-making for blood safety: preliminary report of a consensus conferenceQ37903892
Platelet storage and transfusions: new concerns associated with an old therapyQ38015853
Challenges and promises for the development of donor-independent platelet transfusionsQ38074224
Platelet transfusion: a systematic review of the clinical evidenceQ38267183
Deriving blood stem cells from pluripotent stem cells for research and therapyQ38279078
Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demandsQ38332335
Bleeding during critical illness: a prospective cohort study using a new measurement tool.Q40180744
Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgeryQ40601451
Diagnostic randomized controlled trials: the final frontierQ41231422
Cultured blood versus donated blood: long-run perspectives of the economy of bloodQ41653001
Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood lossQ43700338
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt traumaQ45343282
Impact of ABO-Identical vs ABO-Compatible Nonidentical Plasma Transfusion in Trauma PatientsQ46778443
Physiologic transfusion triggersQ47573609
An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME).Q48085790
Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses.Q50460022
Additive solution-7 reduces the red blood cell cold storage lesion.Q50460076
The use of lyophilized plasma in a severe multi-injury pig model.Q50496754
Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.Q50646739
Menopausal status affects the susceptibility of stored RBCs to mechanical stress.Q51476501
Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy.Q53205612
Post-transfusion mortality among recipients of ABO-compatible but non-identical plasmaQ57579836
Transfusion of ABO-mismatched platelets leads to early platelet refractorinessQ68534410
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell DiseaseQ68545154
Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathyQ84190075
Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patientsQ84853003
P433issue9
P407language of work or nameEnglishQ1860
P304page(s)2282-2290
P577publication date2015-08-10
P1433published inTransfusionQ15758500
P1476title2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium
P478volume55

Reverse relations

cites work (P2860)
Q476105072017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.
Q36821022A Comparative Study of the Effect of Leukoreduction and Pre-storage Leukodepletion on Red Blood Cells during Storage
Q90316062A rose is a rose is a rose, or not
Q39179984Bio-inspired nanomedicine strategies for artificial blood components
Q47324534Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.
Q46460311Citrate metabolism in red blood cells stored in additive solution-3.
Q88706622Development, validation, and potential applications of biotinylated red blood cells for posttransfusion kinetics and other physiological studies: evidenced-based analysis and recommendations
Q38963866Do we need [more] clinical trials in Transfusion Medicine and Hemotherapy?
Q92654817Electron paramagnetic resonance oximetry as a novel approach to monitor the effectiveness and quality of red blood cell transfusions
Q33689210Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays
Q57794948Heterogeneity of blood processing and storage additives in different centers impacts stored red blood cell metabolism as much as storage time: lessons from REDS-III-Omics
Q61808594Hitchhiker's guide to the red blood cell storage lesion
Q38739597Hitchhiker's guide to the red cell storage galaxy: Omics technologies and the quality issue
Q49305174Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage
Q33437439In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice
Q38667980Metabolomics in transfusion medicine
Q37679821Omics markers of the red cell storage lesion and metabolic linkage
Q55220761Pediatric and Neonatal Transfusion Medicine: A Roadmap for Research.
Q91067835Plasma for direct therapeutic use, for today and tomorrow: A short critical overview
Q50213413Red blood cell metabolic responses to refrigerated storage, rejuvenation, and frozen storage
Q54963478Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study.
Q50265769Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology
Q90480268The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia
Q39185581The intensive care medicine clinical research agenda in paediatrics.
Q38815368Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness